Revenue from Contracts with Customers - Disaggregation of Revenue (Details) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026 USD ($)	Jun. 30, 2025 USD ($)	Jun. 30, 2026 USD ($) segment item	Jun. 30, 2025 USD ($)
Disaggregation of Revenue [Line Items]
Number of operating segments \| segment			1
Number of product categories \| item			2
Revenue	$ 418,843	$ 382,462	$ 800,720	$ 737,813
Foundational
Disaggregation of Revenue [Line Items]
Revenue	280,961	262,382	536,440	502,764
Access
Disaggregation of Revenue [Line Items]
Revenue	161,786	152,122	312,910	286,520
OEM
Disaggregation of Revenue [Line Items]
Revenue	48,338	43,218	87,878	86,641
Procedural Solutions
Disaggregation of Revenue [Line Items]
Revenue	27,949	31,741	54,437	60,310
Vascular Intervention
Disaggregation of Revenue [Line Items]
Revenue	41,652	34,955	80,690	67,804
Other
Disaggregation of Revenue [Line Items]
Revenue	1,236	346	525	1,489
Therapeutic
Disaggregation of Revenue [Line Items]
Revenue	137,882	120,080	264,280	235,049
Cardiac Therapies
Disaggregation of Revenue [Line Items]
Revenue	28,510	22,930	55,914	43,489
Endoscopy
Disaggregation of Revenue [Line Items]
Revenue	23,647	18,400	45,339	34,951
OEM
Disaggregation of Revenue [Line Items]
Revenue	12,797	9,735	20,276	20,877
Oncology
Disaggregation of Revenue [Line Items]
Revenue	25,774	23,943	49,282	45,994
Renal Therapies
Disaggregation of Revenue [Line Items]
Revenue	12,713	12,817	24,225	26,206
Vascular Intervention
Disaggregation of Revenue [Line Items]
Revenue	34,441	32,255	69,244	63,532
United States
Disaggregation of Revenue [Line Items]
Revenue	252,051	227,082	478,567	440,646
International
Disaggregation of Revenue [Line Items]
Revenue	$ 166,792	$ 155,380	$ 322,153	$ 297,167